Drug

TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived…

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 First Potential Approval of an Individualized, One-Time Cell Therapy for Patients with Advanced Melanoma SAN CARLOS, Calif., May…

— Prescription Drug User Fee Act (PDUFA) Target Action Date set…

Company Announcement Results from phase 2 clinical trial…

FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar…

Company on track to complete planned interim analyses from two…

TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular…

TOKYO and CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) --…

CALGARY, Alberta, April 21, 2023 (GLOBE NEWSWIRE) -- XORTX…

Ad hoc…